liver failure

Make a delay and accumulation of outstanding tasks Full stop

Biotech

Genfit ends liver failure program over phase 2 safety signal

Genfit has stopped development of VS-01 in acute-on-chronic liver failure after a patient suffered a serious adverse event in a phase 2 trial.

Nick Paul Taylor Sep 22, 2025 5:14am

speedometer accelerate fast speed push

Genfit moves to jump-start enrollment in liver failure trial

Sep 20, 2024 9:47am

image of a chain with a padclock keeping a gate closed

Rapt faces clinical hold after liver failure in immunology trial

Feb 20, 2024 10:42am

plan B fail reroute road path trail miss

Galecto cans lung fibrosis med after ph. 2 fail, pivots to liver

Aug 15, 2023 7:30am

Illustration connected puzzle pieces with the acronym MA

Genfit revs up liver failure strategy with $41M biotech buyout

Sep 19, 2022 7:00am

Novartis taps Alnylam for ambitious push to fix liver function

Jan 6, 2022 8:00am